论文部分内容阅读
[Wang RYC等:J Chin Pharmacol 1983:23:362-368(英文)]间羟叔丁肾上腺素已显示对心力衰竭患者具有有益的血液动力学作用。而对于其在冠心病心衰时的应用之可能顾虑是该药的心脏刺激作用可能超过其有益的血液动力学作用而使潜在的缺血情况加重。本研究旨在评价静脉间羟叔丁肾上腺素对9名冠心病所致的严重心衰病人的作用。
[Wang RYC et al .: J Chin Pharmacol 1983: 23: 362-368 (in English)] Metbutamine has been shown to have a beneficial hemodynamic effect in patients with heart failure. A possible concern for its use in heart failure with coronary heart disease is that the cardiotropic effects of the drug may outweigh its beneficial hemodynamic effects and exacerbate underlying ischemic conditions. This study was designed to evaluate the role of intravenous oxytocin in patients with severe heart failure caused by 9 coronary heart disease.